Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
Of the 300 patients in the PARCER trial, 93 faced grades ≥2 adverse events (3D-CRT = 59, IG-IMRT = 34). Patients in the 3D-CRT and IG-IMRT arms spent an average of 2.39 years and 1.96 years in ...
5don MSN
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers
A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were ...
Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...
According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...
Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby ...
Early initiation of salvage radiotherapy is associated with improved metastasis-free survival in patients with relapsed prostate cancer following prostatectomy. Survival outcomes in men with ...
Patients with oropharyngeal carcinoma who receive proton therapy are more likely to develop this potentially debilitating complication than those who receive IMRT, a new study finds.
Explore how advancements in robotic surgery and radiation therapy are revolutionizing cancer care with precision and improved ...
After a radical hysterectomy and pelvic lymphadenectomy for early-stage cervical cancer, patients often face decisions about ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback